Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

efzofitimod 450 mg - Phase 2 | LIFE Pipeline | CatalystAlert

efzofitimod 450 mg

Phase 2

aTyr Pharma, Inc. (LIFE)

16%

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Apr 2026~

LIFEPhase 2Phase 2

efzofitimod 450 mg Phase 2 Results Expected

efzofitimod 450 mg • Interstitial Lung Disease

Drug Information

Target Indication

Interstitial Lung Disease

Clinical Trial

Last updated: 12/4/2025

Developer

LIFE

aTyr Pharma, Inc.

Biotechnology•North America•NASDAQ